Response to Letter to the Editor Regarding "Abiraterone Acetate for the Treatment of Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer": An Evidence Review Group Perspectiveaof a NICE Single Technology Appraisal

Bram L. T. Ramaekers*, Rob Riemsma, Florian Tomini, Thea van Asselt, Sohan Deshpande, Steven Duffy, Nigel Armstrong, Johan L. Severens, Jos Kleijnen, Manuela A. Joore

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)665-667
Number of pages3
Issue number6
Publication statusPublished - Jun 2017

Cite this